Published in Eur J Clin Nutr on September 16, 2009
Coffee consumption but not green tea consumption is associated with adiponectin levels in Japanese males. Eur J Nutr (2010) 0.89
Markers of increased cardiovascular risk in postmenopausal women: focus on oxidized-LDL and HDL subpopulations. Dis Markers (2013) 0.88
Coffee and tea consumption in relation to inflammation and basal glucose metabolism in a multi-ethnic Asian population: a cross-sectional study. Nutr J (2011) 0.80
Adolescent-Onset Depression: Are Obesity and Inflammation Developmental Mechanisms or Outcomes? Child Psychiatry Hum Dev (2015) 0.79
Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease. Int J Clin Exp Pathol (2015) 0.77
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med (2004) 15.30
Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67
Coffee consumption and risk of type 2 diabetes mellitus. Lancet (2002) 4.64
Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA (2005) 4.14
Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol (2001) 2.44
Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation (1999) 1.96
Dose Response to Exercise in Women aged 45-75 yr (DREW): design and rationale. Med Sci Sports Exerc (2004) 1.92
Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr (2006) 1.79
Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J (2004) 1.73
Beverage consumption in the US population. J Am Diet Assoc (2006) 1.69
Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr (2006) 1.64
Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem (1998) 1.43
Risk of type 2 diabetes attributable to C-reactive protein and other risk factors. Diabetes Care (2007) 1.34
Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer (2008) 1.19
Impact of C-reactive protein on disease risk and its relation to dietary factors. Asian Pac J Cancer Prev (2007) 1.11
Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr (2004) 1.07
Waist circumference is the main determinant of elevated C-reactive protein in metabolic syndrome. Diabetes Res Clin Pract (2007) 0.99
Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response. Circulation (2003) 0.98
Body weight and oral contraceptives are the most important modulators of serum CRP levels. Scand J Clin Lab Invest (2007) 0.87
The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population. Clin Chem Lab Med (2008) 0.86
Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity. Am J Obstet Gynecol (2007) 0.84
Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA (1995) 38.40
Physical activity assessment methodology in the Five-City Project. Am J Epidemiol (1985) 7.90
Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized trial. JAMA (1999) 7.88
Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol (1985) 6.10
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern Med (2000) 5.58
Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA (1999) 4.90
Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr (1999) 4.64
Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care (1990) 4.49
How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st Stock Conference and consensus statement. Obes Rev (2003) 4.03
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med (2000) 3.66
The public health burdens of sedentary living habits: theoretical but realistic estimates. Med Sci Sports Exerc (1994) 3.38
Measurement of physical activity to assess health effects in free-living populations. Med Sci Sports Exerc (1993) 3.10
Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA (1984) 2.90
Comparisons of leisure-time physical activity and cardiorespiratory fitness as predictors of all-cause mortality in men and women. Br J Sports Med (2010) 2.84
Physical activity behavior change: issues in adoption and maintenance. Health Psychol (2000) 2.75
A comparative evaluation of three accelerometry-based physical activity monitors. Med Sci Sports Exerc (2000) 2.75
A mail survey of physical activity habits as related to measured physical fitness. Am J Epidemiol (1988) 2.72
Determinants of physical activity and interventions in adults. Med Sci Sports Exerc (1992) 2.66
Relationships between exercise or physical activity and other health behaviors. Public Health Rep (1985) 2.47
Reduction in cardiovascular disease risk factors: 6-month results from Project Active. Prev Med (1997) 2.41
Encouraging patients to become more physically active: the physician's role. Ann Intern Med (1997) 2.37
The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Ann Intern Med (1999) 2.34
Health-related physical fitness in childhood: status and recommendations. Annu Rev Public Health (1988) 2.32
Prediction of functional aerobic capacity without exercise testing. Med Sci Sports Exerc (1990) 2.28
Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference? Obes Rev (2007) 2.10
Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther (2010) 2.06
Physical activity, physical fitness, and all-cause and cancer mortality: a prospective study of men and women. Ann Epidemiol (1996) 1.95
The utility of the Digi-walker step counter to assess daily physical activity patterns. Med Sci Sports Exerc (2000) 1.87
Patterns of non-response to a mail survey. J Clin Epidemiol (1990) 1.87
Association of sleep duration with type 2 diabetes and impaired glucose tolerance. Diabetologia (2007) 1.87
Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int J Obes (Lond) (2007) 1.85
Cost-effectiveness of lifestyle and structured exercise interventions in sedentary adults: results of project ACTIVE. Am J Prev Med (2000) 1.84
Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol (1994) 1.75
Increased exercise level and plasma lipoprotein concentrations: a one-year, randomized, controlled study in sedentary, middle-aged men. Metabolism (1983) 1.69
The safety of maximal exercise testing. Circulation (1989) 1.68
Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis. Heart (2007) 1.67
Physical activity and self-reported, physician-diagnosed osteoarthritis: is physical activity a risk factor? J Clin Epidemiol (2000) 1.59
A conceptual framework for performance diagnosis and training prescription from submaximal gas exchange parameters--theory and application. Int J Sports Med (2005) 1.56
Six-month physical activity and fitness changes in Project Active, a randomized trial. Med Sci Sports Exerc (1998) 1.54
Weighing the options: criteria for evaluating weight-management programs. The Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity. Obes Res (1995) 1.52
AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel. J Am Coll Cardiol (1995) 1.52
Maximal exercise test as a predictor of risk for mortality from coronary heart disease in asymptomatic men. Am J Cardiol (2000) 1.51
Dose of exercise and health benefits. Arch Intern Med (1997) 1.43
Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thromb Vasc Biol (2002) 1.42
Effects of physical activity on exercise tests and respiratory function. Br J Sports Med (2003) 1.41
Heart rate variability, trait anxiety, and perceived stress among physically fit men and women. Int J Psychophysiol (2000) 1.41
Retention rates and weight loss in a commercial weight loss program. Int J Obes (Lond) (2006) 1.41
Giro, Tour, and Vuelta in the same season. Br J Sports Med (2003) 1.39
Alcohol intake and incidence of type 2 diabetes in men. Diabetes Care (2000) 1.37
Preventing heart attack and death in patients with coronary disease. Circulation (1995) 1.36
Physical activity patterns associated with cardiorespiratory fitness and reduced mortality: the Aerobics Center Longitudinal Study. Am J Public Health (1998) 1.36
Physical fitness, mortality and obesity. Int J Obes Relat Metab Disord (1995) 1.35
Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease. Am Heart J (1985) 1.35
Association among physical activity level, cardiorespiratory fitness, and risk of musculoskeletal injury. Am J Epidemiol (2001) 1.33
Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia (2009) 1.28
A public health intervention model for work-site health promotion. Impact on exercise and physical fitness in a health promotion plan after 24 months. JAMA (1986) 1.26
Estimated change in physical activity level (PAL) and prediction of 5-year weight change in men: the Aerobics Center Longitudinal Study. Int J Obes Relat Metab Disord (2004) 1.25
Changes in aerobic power of men, ages 25-70 yr. Med Sci Sports Exerc (1995) 1.24
Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation (2000) 1.24
The effects of aerobic exercise on plasma catecholamines and blood pressure in patients with mild essential hypertension. JAMA (1985) 1.22
The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Québec Family Study. Clin Genet (2003) 1.18
Do 6-y changes in eating behaviors predict changes in body weight? Results from the Québec Family Study. Int J Obes Relat Metab Disord (2003) 1.18
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol (2001) 1.17
Aerobic fitness, body mass index, and CVD risk factors among adolescents: the Québec family study. Int J Obes (Lond) (2005) 1.16
Influences of cardiorespiratory fitness levels and other predictors on cardiovascular disease mortality in men. Med Sci Sports Exerc (1998) 1.16
Combined aerobic and resistance training in breast cancer survivors: A randomized, controlled pilot trial. Int J Sports Med (2006) 1.16
Changes in aerobic power of women, ages 20-64 yr. Med Sci Sports Exerc (1996) 1.16
Does physical activity ameliorate the health hazards of obesity? Br J Sports Med (2008) 1.15
Physical fitness, physical activity, and functional limitation in adults aged 40 and older. Med Sci Sports Exerc (1998) 1.15
Association between coronary heart disease risk factors and physical fitness in healthy adult women. Circulation (1983) 1.15
Genome-wide linkage scan reveals multiple susceptibility loci influencing lipid and lipoprotein levels in the Quebec Family Study. J Lipid Res (2003) 1.13
US weight guidelines: is it also important to consider cardiorespiratory fitness? Int J Obes Relat Metab Disord (1998) 1.11
Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome. Int J Obes Relat Metab Disord (2002) 1.11
Comparison of nutrient intake in middle-aged men and women runners and controls. Med Sci Sports Exerc (1981) 1.10
Exaggerated blood pressure response to dynamic exercise and risk of future hypertension. J Clin Epidemiol (1998) 1.10
Muscular strength and physical function. Med Sci Sports Exerc (2000) 1.09
Health promotion for educators: impact on absenteeism. Prev Med (1986) 1.09
Childhood and adolescent physical activity patterns and adult physical activity. Med Sci Sports Exerc (1999) 1.08
Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Med Sci Sports Exerc (2001) 1.07
Physical inactivity, abdominal obesity and risk of coronary heart disease in apparently healthy men and women. Int J Obes (Lond) (2009) 1.06
The relationship between sociodemographic characteristics and recruitment, retention, and health improvements in a worksite health promotion program. Am J Health Promot (1993) 1.06
The inverse relationship between number of steps per day and obesity in a population-based sample: the AusDiab study. Int J Obes (Lond) (2006) 1.06
Longer sleep duration associates with lower adiposity gain in adult short sleepers. Int J Obes (Lond) (2011) 1.06
The potential role of physical activity in the prevention of non-insulin-dependent diabetes mellitus: the epidemiological evidence. Exerc Sport Sci Rev (1994) 1.05
Nutrient intake of physically fit and unfit men and women. Med Sci Sports Exerc (2001) 1.05
The effect of amphetamines on selected physiological components related to athletic success. Med Sci Sports Exerc (1980) 1.04
A history of physical activity, cardiovascular health and longevity: the scientific contributions of Jeremy N Morris, DSc, DPH, FRCP. Int J Epidemiol (2001) 1.04
Physical fitness levels among European adolescents: the HELENA study. Br J Sports Med (2009) 1.03
Physical fitness and clustering of risk factors associated with the metabolic syndrome. Med Sci Sports Exerc (1999) 1.01
Cardiovascular safety of maximal strength testing in healthy adults. Am J Cardiol (1995) 1.00
Does weight loss cause the exercise-induced increase in plasma high density lipoproteins? Atherosclerosis (1983) 1.00
Which laboratory variable is related with time trial performance time in the Tour de France? Br J Sports Med (2004) 1.00